Ozge Gumusay
Ozge Gumusay
UCSF Helen Diller Family Comprehensive Cancer Center
ucsf.edu üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Diagnostic potential of serum direct markers and non‐invasive fibrosis models in patients with chronic hepatitis B
Ö Gümüşay, S Özenirler, A Atak, C Sönmez, S Özkan, AF Tuncel, ...
Hepatology Research 43 (3), 228-237, 2013
382013
Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival …
MA Kaplan, A Isikdogan, D Koca, M Kucukoner, O Gumusay, R Yildiz, ...
Breast cancer 21 (6), 677-683, 2014
372014
Biological subtypes and survival outcomes in breast cancer patients with brain metastases (study of the Anatolian Society of Medical Oncology)
MA Kaplan, A Isikdogan, D Koca, M Kucukoner, O Gumusay, R Yildiz, ...
Oncology 83 (3), 141-150, 2012
212012
Association between hemoglobin, calcium, and lactate dehydrogenase variability and mortality among metastatic renal cell carcinoma
B Cetin, B Afsar, SM Deger, II Gonul, O Gumusay, A Ozet, M Benekli, ...
International urology and nephrology 46 (6), 1081-1087, 2014
202014
Advances of molecular targeted therapy in gastric cancer
B Cetin, O Gumusay, M Cengiz, A Ozet
Journal of gastrointestinal cancer 47 (2), 125-134, 2016
182016
Discordances in HER2 status between primary gastric cancer and corresponding metastatic sites
O Gumusay, M Benekli, O Ekinci, M Baykara, A Ozet, U Coskun, ...
Japanese journal of clinical oncology 45 (5), 416-421, 2015
182015
Oral etoposide for platinum-resistant and recurrent epithelial ovarian cancer: a study by the Anatolian Society of Medical Oncology
M Kucukoner, A Isikdogan, S Yaman, O Gumusay, O Unal, A Ulas, ...
Asian Pacific Journal of Cancer Prevention 13 (8), 3973-3976, 2012
182012
Predictive factors for the development of brain metastases in patients with malignant melanoma: a study by the Anatolian society of medical oncology
O Gumusay, U Coskun, T Akman, AS Ekinci, M Kocar, ÖB Erceleb, ...
Journal of cancer research and clinical oncology 140 (1), 151-157, 2014
152014
Carbonic anhydrase IX is a prognostic biomarker in glioblastoma multiforme
B Cetin, II Gonul, O Gumusay, I Bilgetekin, E Algin, A Ozet, A Uner
Neuropathology 38 (5), 457-462, 2018
122018
Factors influencing chemotherapy goal perception in newly diagnosed cancer patients
O Gumusay, B Cetin, M Benekli, G Gurcan, MN Ilhan, B Bostankolu, ...
Journal of Cancer Education 31 (2), 308-313, 2016
102016
Comparison of three different concurrent chemoradiation regimens for treatment of laryngeal cancer
U Aydil, M Akmansu, Ö Gumusay, FK Bakkal, Y Kızıl, A Köybaşıoğlu, ...
European Archives of Oto-Rhino-Laryngology 273 (9), 2795-2803, 2016
62016
Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naïve breast cancer: real-life practice outcomes
E Esin, B Oksuzoglu, A Bilici, I Cicin, O Kostek, MA Kaplan, S Aksoy, ...
Cancer chemotherapy and pharmacology 83 (1), 131-143, 2019
52019
The impact of immunohistochemical staining with ezrin-carbonic anhydrase IX and neuropilin-2 on prognosis in patients with metastatic renal cell cancer receiving tyrosine …
B Cetin, II Gonul, S Buyukberber, B Afsar, O Gumusay, E Algın, N Turan, ...
Tumor Biology 36 (11), 8471-8478, 2015
52015
Small cell neuroendocrine carcinoma of the posterior tongue
O Gumusay, G Yilmaz, U Aydil, A Ozet, G Tufan, O Erdem, Y Kizil, ...
Journal of cancer research and therapeutics 11 (3), 651, 2015
52015
Factors predicting recurrence in patients with grade III glial tumors: Impact of adjuvant temozolomide on recurrence
O Gumusay, B Cetin, A Ozet, U Demirci, S Buyukberber, U Coskun, ...
J BUON 19 (4), 1035-1040, 2014
52014
Failure of concurrent chemoradiotherapy for organ preservation in laryngeal cancer: survival outcomes and recurrence patterns
U Aydil, M Akmansu, Ö Gümüşay, FC Eravcı, FK Bakkal, Ö Yazıcı, Y Kızıl, ...
Ear, Nose & Throat Journal 98 (7), E92-E96, 2019
42019
Factors predicting the development of distant metastases in patients with head and neck squamous cell carcinoma: a retrospective study from a single centre
O Gumusay, A Ozet, S Buyukberber, M Baykara, U Coskun, B Cetin, ...
J BUON 20 (2), 521-526, 2015
42015
Lapatinib or trastuzumab? Which anti-HER2 treatment is more effective in the treatment of patients with HER2-positive breast cancer with brain metastases? An Anatolian Society …
MA Kaplan, A Isikdogan, D Koca, M Kucukoner, O Gumusay, R Yildiz, ...
Journal of Clinical Oncology 30 (15_suppl), 638-638, 2012
42012
Association between survival and maximum standardized uptake value of liver metastases detected by 18-fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography …
E Algin, A Ozet, O Gumusay, B Cetin, UO Akdemir, M Benekli, U Coskun, ...
Annals of nuclear medicine 28 (9), 891-896, 2014
32014
Pembrolizumab for early triple-negative breast cancer
B Cetin, O Gumusay, P Schmid, R Dent, J O’Shaughnessy
N. Engl. J. Med 382, e108, 2020
22020
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20